The short version of immunomodulatory peptide fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2026-05-16 and is reviewed periodically as new material appears.
Biologically, the peptide is studied mainly in the context of immune cell development and regulation. It is produced in the thymus and in several other tissues, and it appears to influence the maturation and activity of T cells and other immune populations. Laboratory work describes effects on cytokine production, on the balance between T cell subsets, and on the function of dendritic cells. Much of this evidence comes from cell culture and animal models, so the extent to which the same pathways operate in humans remains an open question.
Clinical interest has centered on chronic viral hepatitis, on immune restoration in various conditions, and on use as an adjuvant intended to improve responses to vaccines. Trials have reported mixed results, and regulatory status differs sharply between countries; in some places it is a prescription product, while elsewhere it is sold without an approved therapeutic indication. Because published studies vary widely in design, population, and endpoints, comparisons across them are difficult and no single conclusion covers the whole literature.
Thymosin alpha 1 is a short peptide of 28 amino acid residues that derives from the amino terminal region of a larger precursor protein known as prothymosin alpha. The peptide carries an acetyl group on its first residue and contains no disulfide bonds or carbohydrate chains. Its sequence is highly conserved across mammalian species, which is one reason laboratories treat it as a molecule with a defined and reproducible structure rather than a variable tissue extract. The name follows an early naming convention for thymus-derived fractions and does not imply that the peptide acts as a hormone in the classical endocrine sense.
The peptide was described in the 1970s as a component of thymic extracts, and early research focused on restoring immune function in immunodeficiency states. A synthetic version entered clinical development in the 1980s and is approved as a drug in several countries for conditions such as chronic hepatitis B and certain immunodeficiencies. Approval status varies widely by jurisdiction, and in the United States it is not an approved therapeutic. Regulatory and clinical positions differ, so statements about efficacy should be tied to specific indications and studies.
Thymosin alpha-1 is a synthetic peptide of 28 amino acids, corresponding to the N-terminal fragment of prothymosin alpha. Its sequence begins with acetylation at the N-terminus, a modification that affects stability and receptor interaction. The peptide is acidic, with a calculated isoelectric point near 4.2, and carries no disulfide bonds, so its secondary structure is largely flexible in solution. Molecular mass is approximately 3108 daltons. The native form was first isolated from bovine thymus tissue, while pharmaceutical material is produced by solid-phase peptide synthesis.
| Property | Value | Notes |
|---|---|---|
| Molecular mass | Approximately 3,108 Da | Consistent with a 28-residue acetylated peptide |
| Residue count | 28 | Corresponds to the amino terminal region of prothymosin alpha |
| Appearance of dry powder | White to off-white solid | Slight variation between lots is normal |
| Solubility class | Freely soluble in water | Low solubility in most organic solvents |
| Common synonyms | Thymosin alpha 1, T alpha 1 | The numeral reflects an early fraction numbering scheme |
The molecule consists of 28 amino acid residues with an acetyl group attached to the N-terminal serine. Its sequence is acidic overall, with several glutamic and aspartic acid residues distributed along the chain and no cysteine, so disulfide bridges do not form. The peptide carries a net negative charge at physiological pH. Because the N-terminus is blocked, the intact molecule resists degradation by many aminopeptidases, which contributes to its stability in biological fluids.
The peptide is generated in cells by cleavage of prothymosin alpha, a larger acidic protein encoded by the PTMA gene. Prothymosin alpha is expressed in many tissues, not only in the thymus, and its functions include nuclear roles in chromatin-related processes. The 28-residue fragment corresponds to the N-terminal portion of that precursor. How the cleavage occurs and how the fragment's concentration is regulated remain open questions; circulating amounts are small and difficult to measure reliably with routine assays.
Clinical research has examined the peptide in chronic hepatitis B and C, as a vaccine adjuvant, and in sepsis and oncology settings. Results across trials have been mixed, and several studies were small or conducted under differing protocols. Regulatory status varies by country, and the compound is not approved in every jurisdiction where it is studied. Evidence for any single indication should be read with attention to sample size and endpoint choice.
Thymosin alpha-1 is a 28-residue peptide first isolated from thymus tissue in the 1970s. It corresponds to the N-terminal portion of thymosin beta-4, from which it is cleaved in vivo. The peptide carries an acetyl group at its N-terminus, a modification that affects its charge and stability. Synthetic material produced by solid-phase peptide synthesis is chemically identical to the natural fragment and is the form used in research and clinical studies.
Whether the free 28-residue peptide circulates in human tissue remains debated. The best-documented human source is prothymosin alpha, a larger acidic protein that carries the sequence at its N-terminus. Reports of measurable peptide levels in serum and lymphoid tissue exist, yet some of that signal may come from cross-reacting fragments or from the parent protein. Most reviews therefore treat prothymosin alpha as the established human molecule and describe independent circulation of the small peptide as an unresolved question.
Immunological studies connect the peptide to multiple parts of the immune response. It has been reported to engage Toll-like receptor signaling, to promote dendritic cell maturation, and to influence the balance of T helper cell subsets. Changes in natural killer cell activity and in cytokine release appear in cell culture and animal models. These observations describe broad immunomodulatory behavior rather than a single defined receptor target, and the primary molecular interaction has not been settled.
Most published studies on thymosin alpha-1 report changes in immune measurements rather than clinical outcomes, and findings differ across designs and populations. Whether the peptide signals through one defined receptor or through several less specific interactions remains an open question. Its reported circulation half-life of a few hours complicates comparison of dosing schedules across trials. Mechanistic claims are frequently drawn from isolated cell cultures, and how far those results extend to whole organisms is unresolved.
Thymosin alpha-1 is a synthetic peptide of 28 amino acids whose sequence matches the amino-terminal region of prothymosin alpha. The chain is acetylated at its first residue and contains one disulfide bridge between two cysteine residues, which folds the molecule into a compact loop. Its molecular formula, C129H215N33O55, corresponds to a monoisotopic mass of roughly 3,106 daltons. Material used in laboratories is made by solid-phase synthesis rather than isolated from animal tissue.
Herringbone stitch secures the edges of a textile to a backing fabric. This stitch is also a flexible way to join more than one layer of fabric. Herrigbone stitch is similar to a cross stitch with interlocking stitches. Slip-stitch is used to secure a backing fabric and is nearly invisible on the right side of the fabric. Couching is the most commonly used stitching method in textile stabilization. Torn, frayed, or weak areas can be secured to a support fabric with couching. Generally, a 5mm stitch spacing will give stability and be quicker to stitch than a closer spacing. Darning stitch is used to cover areas of loss and prevent further degradation. Laid couching is a long straight stitch, held in place with short perpendicular stitches. Brick couching is a short stitch placed over one or several threads and sewn in a brick-work like pattern. Thread types cotton thread is the most commonly used thread for stabilizing textiles. Fine polyester is also acceptable.
Laurence Fox is arrested "on suspicion of conspiring to commit criminal damage to ULEZ cameras and encouraging or assisting offences to be committed." He is subsequently fired from GB News, along with fellow presenter Calvin Robinson. Cheshire Police confirm they have launched an investigation into possible corporate manslaughter at the Countess of Chester Hospital, where killer nurse Lucy Letby was employed. 5 October Jaswant Singh Chail, 21, becomes the first person in the UK to be convicted of treason since 1981, after taking a crossbow to Windsor Castle and intending to kill Queen Elizabeth II. The Metropolitan Police announce that 21 people arrested during the King's Coronation will face no further charges. 2023 Cricket World Cup in India, England competes in the 2023 Cricket World Cup. 5–6 October – 2023 Rutherglen and Hamilton West by-election: Labour's Michael Shanks wins, resoundingly defeating the incumbent SNP by a swing of over 20%. 7 October – The Criminal Cases Review Commission is to review the conviction of Michael Stone for the 1996 murders of Lin and Megan Russell after serial killer Levi Bellfield is reported to have confessed to the murders.
is the speed of light in vacuum. Typical metals that support surface plasmons are silver and gold, but metals such as copper, titanium or chromium have also been used. When using light to excite SP waves, there are two configurations which are well known. In the Otto configuration, the light illuminates the wall of a glass block, typically a prism, and is totally internally reflected. A thin metal film (for example gold) is positioned close enough to the prism wall so that an evanescent wave can interact with the plasma waves on the surface and hence excite the plasmons. In the Kretschmann configuration (also known as Kretschmann–Raether configuration), the metal film is evaporated onto the glass block. The light again illuminates the glass block, and an evanescent wave penetrates through the metal film. The plasmons are excited at the outer side of the film. This configuration is used in most practical applications.
And 5) GLPG0974 is an allosteric antagonist, i.e., it inhibits human FFAR2 by binding to a site different than the SCFAs' binding site. GLPGO908 does not bind to or inhibit rodent FFAR2 but nonetheless GLPG0974 does have effects in rodents. Off-target actions such as these need to be but often are not considered in studies on the actions of SCFAs and FFAR2 drugs. Furthermore, SCFAs have many actions that do not involve FFAR2, e.g., they activate FFAR3, GPR109A (now termed hydroxycarboxylic acid receptor 2 or HCA2), and two other GPRs, Olfr78 and Olfr558. Most of the studies reported here include experiments in which the actions of SCFAs and FFAR2-regulating drugs in cells and animals are further tested in the cells and animals that have been made to express relatively little or no FFAR2 using gene knockdown or gene knockout methods, respectively. The effects of SCFAs and the drugs should be reduced or absent in cells and animals that under-express or lack FFAR2.
== Gastroenterology == In gastroenterology, the term overlap syndrome may be used to describe autoimmune liver diseases that combine characteristic features of autoimmune hepatitis, primary biliary cirrhosis and primary sclerosing cholangitis.
Sources: en.wikipedia.org
=== Reports === Many organizations have published reports pertaining to obesity. In 1998, the first US Federal guidelines were published, titled "Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: The Evidence Report". In 2006, the Canadian Obesity Network, now known as Obesity Canada published the "Canadian Clinical Practice Guidelines (CPG) on the Management and Prevention of Obesity in Adults and Children". This is a comprehensive evidence-based guideline to address the management and prevention of overweight and obesity in adults and children. In 2004, the United Kingdom Royal College of Physicians, the Faculty of Public Health and the Royal College of Paediatrics and Child Health released the report "Storing up Problems", which highlighted the growing problem of obesity in the UK. The same year, the House of Commons Health Select Committee published its "most comprehensive inquiry [...] ever undertaken" into the impact of obesity on health and society in the UK and possible approaches to the problem. In 2006, the National Institute for Health and Clinical Excellence (NICE) issued a guideline on the diagnosis and management of obesity, as well as policy implications for non-healthcare organizations such as local councils. A 2007 report produced by Derek Wanless for the King's Fund warned that unless further action was taken, obesity had the capacity to debilitate the National Health Service financially.
The roots of the modern Riksdag can be found in a 1435 meeting in the city of Arboga; however, only three of the estates were probably present: the nobility, the clergy and the burghers. This informal organization was modified in 1527 by the first modern Swedish king, Gustav I Vasa, to include representatives from all the four social estates: the nobility, the clergy, the burghers (property-owning commoners in the towns such as merchants etc.), and the yeomanry (freehold farmers). This form of Ständestaat representation lasted until 1866, when representation by estate was abolished and the modern bicameral parliament established. Effectively, however, it did not become a parliament in the modern sense until parliamentary principles were established in the political system in Sweden in 1917. On 22 June 1866, the Riksdag decided to reconstitute itself as a bicameral legislature, consisting of Första kammaren or the First Chamber, with 155 members and Andra kammaren or the Second Chamber with 233 members. The First Chamber was indirectly elected by county and city councillors, while the Second Chamber was directly elected by universal suffrage. This reform was a result of great discontent with the old Estates, which, following the changes brought by the beginnings of the Industrial Revolution, was no longer able to provide representation for large segments of the population. By an amendment to the 1809 Instrument of Government, the general election of 1970 was the first to a unicameral assembly with 350 seats.
Glutathione S-transferase A3 is an enzyme that in humans is encoded by the GSTA3 gene. Cytosolic and membrane-bound forms of glutathione S-transferase are encoded by two distinct supergene families. These enzymes are involved in cellular defense against toxic, carcinogenic, and pharmacologically active electrophilic compounds. At present, eight distinct classes of the soluble cytoplasmic mammalian glutathione S-transferases have been identified: alpha, kappa, mu, omega, pi, sigma, theta and zeta. This gene encodes a glutathione S-transferase belonging to the alpha class genes that are located in a cluster mapped to chromosome 6. Genes of the alpha class are highly related and encode enzymes with glutathione peroxidase activity. However, during evolution, this alpha class gene diverged accumulating mutations in the active site that resulted in differences in substrate specificity and catalytic activity. The enzyme encoded by this gene catalyzes the double bond isomerization of precursors for progesterone and testosterone during the biosynthesis of steroid hormones. An additional transcript variant has been identified, but its full length sequence has not been determined.
A ribosome is a ribonucleoprotein particle made from complexes of ribosomal RNAs and proteins, arranged into two ribosomal subunits, one large and the other small. Ribosomes are complex molecular machines present in all cells both prokaryotic, and eukaryotic. The ribosomal subunits of prokaryotes and eukaryotes are quite similar. A ribosome is largely made up of specialized non-coding ribosomal RNA (rRNA) as well as dozens of distinct ribosomal proteins (the number varies slightly between species). The ribosomal proteins and rRNAs are arranged into two distinct ribosomal subunits one large and one small. The subunits fit together locking around a strand of mRNA, and work together to translate the mRNA into a polypeptide chain during protein synthesis.
Sources: en.wikipedia.org
=== Dentin graft === Dentin bone, made from extracted teeth, comprises more than 85% of tooth structure, the enamel consists of HA mineral and comprises 10% of tooth structure. Dentin is similar to bone in its chemical composition, by volume 70–75% is HA mineral and 20% organic matrix, mostly fibrous type I collagen. Dentin, like bone, may release growth and differentiating factors while being resorbed by osteoclasts. In order to make the dentin graft usable and bacteria-free, some companies have developed clinical procedures which include grinding, sorting and cleaning of the teeth for immediate or future use. In Korea, the Korea Tooth Bank performed bio-recycling of 38 000 patients' own teeth from January 2009 until October 2012.
==== Liver injury ==== The prosecution argued that liver damage found at the post‑mortem of Child O could only be explained by deliberate harm, contrary to the original pathologist's view that the injury was natural. A senior perinatal pathologist who later reviewed the case said she had seen similar liver injuries arise naturally and described the prosecution expert's position as "naive". Published research documents hundreds of comparable cases occurring naturally in neonates. A joint report by two neonatologists working with Letby's legal team argued that the injury was worsened when a doctor accidentally punctured the liver by misplacing a needle. The prosecution pathologist and an independent expert interviewed by the BBC both said there was no evidence of needle trauma, although the BBC's expert also considered deliberate harm "unlikely". The Lee panel concluded that the doctor's needle may have penetrated the liver but considered it "highly likely" that the initial injury resulted from a traumatic delivery. They described the prosecution's blunt-force trauma hypothesis as "implausible". Neonatologist Mike Hall, who was instructed by Letby's first defence team but not called to testify, disputed the panel's traumatic‑delivery explanation but maintained that there was no evidence of deliberate harm.
=== REM sleep deprivation === Norepinephrine prevents REM sleep, and lack of REM sleep increases noradrenaline secretion as a result of the locus coeruleus not ceasing producing it. It causes neurodegeneration if its loss is sustained for several days.
=== Antagonists and inverse agonists === Non-selective Agouti-related peptide Agouti signalling peptide MC2-selective Atumelnant (CRN04894) MC4-selective HS-014 HS-024 MCL-0042 MCL-0129 MPB-10 SHU-9119 (agonist at MC1 and MC5, antagonist at MC3 and MC4)
=== Norwegian === According to Guinness Book of Records (2001), the longest meaningful word used in Norwegian is minoritetsladningsbærerdiffusjonskoeffisientmålingsapparatur (63 letters), meaning devices for measuring coefficients of diffusion of carriers of minority charges. Nouns, and also verbs and adjectives, can be prefixed as qualifiers to other words quite freely, e.g. to make an unlikely, but understandable and grammatically correct, compound word like damplokomotivfyrbøteraspirantluemerkeprodusentdatterkinoavtaletidspunkt, an agreed meeting time for a cinema date with a daughter of a producer of hat badges for trainees aiming to become firemen on steam locomotives.
Sources: en.wikipedia.org
The name reflects an early convention for naming thymus-derived fractions. The peptide is characterized and measured as a defined molecule, and it does not operate through a single classical endocrine axis.
It corresponds to a fragment of the larger protein prothymosin alpha, which is present in many tissues. The isolated 28-amino-acid peptide was originally obtained from thymus preparations, and the pharmaceutical product is synthesized rather than extracted. The term therefore describes both a natural fragment and a manufactured drug substance.
Thymosin alpha-1 is a single defined 28-residue peptide, while the broader family includes unrelated peptides such as thymosin beta-4. The shared name reflects historical isolation from thymus tissue rather than a common structure. Confusion between the two is common in older literature.
No single pathway fully accounts for its reported effects. Several studies describe interaction with innate immune receptors and downstream cytokine changes, but the complete picture is not settled. Open questions remain about which effects occur at physiological concentrations.